Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Hosts 8th Event in its Coronavirus Virtual Event Series on October 19, 2022
  • USA - English


News provided by

Labroots

Oct 13, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Coronavirus Virtual Event Series, October 19, 2022
Coronavirus Virtual Event Series, October 19, 2022

This free, online event recognizes well-renowned experts who are transforming the advancements in the evolving COVID-19 pandemic

YORBA LINDA, Calif., Oct. 13, 2022 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, today announced the 8th event in its ongoing Coronavirus Virtual Event Series, since the inaugural launch in 2020. This educational forum brings together researchers from an array of disciplines, clinicians, epidemiologists, and scientists across leading medical, industry and academic institutions across the world sharing the latest breakthroughs to address prevention, treatment and management of COVID-19/SARS-CoV-2 and challenges presented.

The pre-eminent meeting continues to reach milestone attendance, offering a comprehensive agenda featuring distinguished speakers and innovators in healthcare today. The preceding (seven) virtual events will remain on demand for continuous viewing of valuable and informative content. The next set of presentations will go live on October 19th, 2022 at 5:30am PDT, on general topics covering epidemiology of COVD-19 – previous, current, and future trends, variants and how the virus changes, global preparedness, testing, research, and diagnostics, vaccines and future vaccines, and lessons learned via live-streaming video webcasts including keynote sessions (with live Q&A), industry-sponsored presentations, and on demand discussions available to watch immediately.

Kicking off the day, Dr. Adolfo Garcia-Sastre Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai will deliver a keynote talk titled, "A Newcastle Disease Virus-Based COVID-19 vaccine." In his keynote, Dr. Scott A. Rivkees Professor of Practice and Vice Chair, Department of Health Services, Policy and Practice Brown University School of Public Health will explore the direct and indirect impact of the COVID-19 pandemic on children. The future of COVID-19: expectations and lessons will be discussed by keynote speaker Dr. Ali H. Mokdad, Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation, and Dr. Yvonne Maldonado, Senior Associate Dean for Faculty Development and Diversity, Taube Endowed Professor of Global Health and Infectious Diseases, Professor of Pediatrics and of Epidemiology and Population Health, Chief, Division of Pediatric Infectious Diseases, Stanford University School of Medicine will share the natural history, diagnosis and monitoring and lessons learned in SARS-CoV-2 and COVID-19 in her keynote presentation. Finally, Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health will delve into advancing toward recovery from post-acute sequalae of SARS-CoV-2 Infection (PASC): the NIH RECOVER Initiative in his keynote talk.

"Despite the success of current SARS-CoV-2 vaccines to dramatically reduce the number of COVID-19 hospitalizations, improved vaccines with increased protection from break-through infections are highly desirable," stated Dr. Adolfo Garcia-Sastre, Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai.

"Our children are our future and have been impacted in so many ways by the pandemic," said Scott Rivkees, MD, Professor of Practice at the Brown School of Public Health. "In addition to comprehending the direct effect of COVID-19 itself on the pediatric population, it is important to also recognize the impact the pandemic has had on families, education, and the practice of pediatrics, and how this impact will last well beyond the end of the pandemic. I am grateful to the Labroots platform for providing a forum to discuss these important issues."

"We have long known that people may suffer persistent symptom complexes after an acute infectious illness, but we have not been able to uncover its cause or devise effective treatments," commented Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health. "Now that COVID-19 has infected almost 100 million Americans, the post viral syndrome, now termed "Long COVID", poses a major health and science challenge. The NIH RECOVER Initiative is built as a comprehensive research program to identify the underlying biology and test potential treatments. It's a pleasure to discuss RECOVER on the Labroots platform."

In addition to keynote presentations, other event highlights include a panel presentation sponsored by LGC Clinical Diagnostics titled, "COVID-19 Testing: Results and Recommendations from the Coronavirus Standards Working Group," with Live Q&A. More informative lectures on Detection of SARS-CoV-2 Neutralizing Antibodies with GenScript's SARS-CoV-2 Surrogate Virus Neutralization (sVNT) Test, A Phase 1 Trial of Cyclosporine for Hospitalized Patients with COVID-19, sponsored by NanoString Technologies, and a Thermo Fisher Scientific sponsored presentation on influenza: an underestimated threat, and much more you won't want to miss!

Produced on Labroots' robust platform while connecting across all desktop and mobile devices, the interactive environment delivers a seamless educational experience for all participants. The interactive event consists of a lobby with leaderboard and gamification, an auditorium featuring live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibit hall to interact with sponsors and view their recent contributions in the field, a poster hall to explore data and engage in live chat conversations, and featuring a poster competition to give your research a competitive edge, and lastly a networking lounge to connect and collaborate with colleagues. By attending this virtual event series, there is potential to earn 1 P.A.C.E. Continuing Education credit per presentation.

To register for the event, click here. Use the hashtag #LRcoronavirus to follow the conversation and connect with other members of the global Coronavirus research community! Follow @Labroots on Twitter and @LabrootsInc on Facebook to connect with our team and stay up to date with the latest Trending News in Coronavirus research.

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Now, Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.